Celebration for three FSE staff members
Three staff members of the Faculty of Science and Engineering (formerly known as the Faculty of Mathematics and Natural Sciences) had something to celebrate recently.
Jan Willem Veening (Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute ) is one of 23 new EMBO Young Investigators. He joins a select network of European top scientists in the Life Sciences. Veening is the only Dutch scientist to be elected this year.
Adri Minnaard (bio-organic chemistry, Stratingh Institute for Chemistry) is part of a consortium which received a $3.5 million grant from the Bill and Melinda Gates Foundation to develop a new tuberculosis vaccine. Minnaard will employ four postdocs over the next one and a half year on this project.
Gerrit Jan Poelarends (Applied microbiology, Groningen Research Institute of Pharmacy ) received a KIEM grant from the Dutch funding agency NWO, to develop a new method to produce vital amino acids that may be used to treat brain disease. This is done in collaboration with the Groningen company Integrex Research.
| Last modified: | 14 December 2020 2.37 p.m. |
More news
-
15 June 2021
From ‘closed’ science to Open Science
Vera Heininga is the Open Science coordinator and future programme leader of the upcoming Open Science programme of the University of Groningen. Together with her colleagues, she created the Open Science Community Groningen (OSCG). She explains...
-
17 May 2021
‘Encouraging young people, that’s my most important job’
Four and a half years ago, he received the Nobel Prize. During the award ceremony in Stockholm, Ben Feringa made a resolution: I will put science on the map. His mission is being given a new boost with the establishment of the Ben Feringa Fund,...
-
10 May 2021
‘Give people with dementia more freedom to organize their own social lives’
Older people with memory problems who live at home are extraordinarily resourceful when it comes to staying in control of their activities outside the home. Demographers Jodi Sturge and Mirjam Klaassens are certainly impressed. ‘It’s not about...